Showing 1 - 5 results of 5 for search 'Preethi Udagama', query time: 0.02s Refine Results
  1. 1
    Selected serum cytokines and nitric oxide as potential multi-marker biosignature panels for Parkinson disease of varying durations: a case-control study

    Selected serum cytokines and nitric oxide as potential multi-marker biosignature panels for Parkinson disease of varying durations: a case-control study by Dilini Rathnayake, Thashi Chang, Preethi Udagama

    Published 2019-04-01
    Get full text
    Article
  2. 2
    Prevention of re-establishment of malaria: historical perspective and future prospects

    Prevention of re-establishment of malaria: historical perspective and future prospects by S. M. Ibraheem Nasir, Sachini Amarasekara, Renu Wickremasinghe, Deepika Fernando, Preethi Udagama

    Published 2020-12-01
    Get full text
    Article
  3. 3
    Promoter Hypermethylation of Tumor-Suppressor Genes <i>p16<sup>INK4a</sup>, RASSF1A, TIMP3</i>, and <i>PCQAP/MED15</i> in Salivary DNA as a Quadruple Biomarker Panel for Early Detection of Oral and Oropharyngeal Cancers

    Promoter Hypermethylation of Tumor-Suppressor Genes <i>p16<sup>INK4a</sup>, RASSF1A, TIMP3</i>, and <i>PCQAP/MED15</i> in Salivary DNA as a Quadruple Biomarker Panel for Early Dete... by Chamikara Liyanage, Asanga Wathupola, Sanjayan Muraleetharan, Kanthi Perera, Chamindie Punyadeera, Preethi Udagama

    Published 2019-04-01
    Get full text
    Article
  4. 4
    Immunological detection of the Weligama coconut leaf wilt disease associated phytoplasma: Development and validation of a polyclonal antibody based indirect ELISA.

    Immunological detection of the Weligama coconut leaf wilt disease associated phytoplasma: Development and validation of a polyclonal antibody based indirect ELISA. by Chamini Kanatiwela-de Silva, Malini Damayanthi, Nalin de Silva, Rohana Wijesekera, Matthew Dickinson, Devaka Weerakoon, Preethi Udagama

    Published 2019-01-01
    Get full text
    Article
  5. 5
    Leflunomide is equally efficacious and safe compared to low dose rituximab in refractory rheumatoid arthritis given in combination with methotrexate: results from a randomized double blind controlled clinical trial

    Leflunomide is equally efficacious and safe compared to low dose rituximab in refractory rheumatoid arthritis given in combination with methotrexate: results from a randomized doub... by Harindu Wijesinghe, Priyadharshini Galappatthy, Rajiva de Silva, Suranjith L. Seneviratne, Ushagowry Saravanamuttu, Preethi Udagama, Melanie Hart, Peter Kelleher, Upul Senerath, Rohini Fernandopulle, Lilani P. Weerasekera, Lalith S. Wijayaratne

    Published 2017-07-01
    Get full text
    Article

Search Tools: